Hurtig H - Search Results

1

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.

Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Brennan L, et al. Among authors: hurtig h. Mov Disord. 2016 Jan;31(1):126-34. doi: 10.1002/mds.26339. Epub 2015 Aug 7. Mov Disord. 2016. PMID: 26249849 Free PMC article.

2

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients.

Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. Stern M, et al. Among authors: hurtig h. Arch Neurol. 1991 Sep;48(9):903-7. doi: 10.1001/archneur.1991.00530210029018. Arch Neurol. 1991. PMID: 1953412

3

Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.

Schmidt ML, Lee VM, Hurtig H, Trojanowski JQ. Schmidt ML, et al. Among authors: hurtig h. Lab Invest. 1988 Oct;59(4):460-6. Lab Invest. 1988. PMID: 2459498

4

Selective expression of epitopes in multiphosphorylation repeats of the high and middle molecular weight neurofilament proteins in Alzheimer neurofibrillary tangles.

Trojanowski JQ, Schmidt ML, Otvos L Jr, Gur RC, Gur RE, Hurtig H, Lee VM. Trojanowski JQ, et al. Among authors: hurtig h. Ann Med. 1989;21(2):113-6. doi: 10.3109/07853898909149196. Ann Med. 1989. PMID: 2475147 Free article. Review.

5

Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease.

Hurtig H, Joyce J, Sladek JR Jr, Trojanowski JQ. Hurtig H, et al. Ann Neurol. 1989 Jun;25(6):607-14. doi: 10.1002/ana.410250613. Ann Neurol. 1989. PMID: 2742361

6

Treatment of organic bipolar mood disorders in Parkinson's disease.

Kim E, Zwil AS, McAllister TW, Glosser DS, Stern M, Hurtig H. Kim E, et al. Among authors: hurtig h. J Neuropsychiatry Clin Neurosci. 1994 Spring;6(2):181-4. doi: 10.1176/jnp.6.2.181. J Neuropsychiatry Clin Neurosci. 1994. PMID: 8044042

7

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.

Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J, et al. Olanow CW, et al. Among authors: hurtig h. Mov Disord. 1994 Jan;9(1):40-7. doi: 10.1002/mds.870090107. Mov Disord. 1994. PMID: 8139604 Clinical Trial.

8

Olfactory function in Parkinson's disease subtypes.

Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Stern MB, et al. Among authors: hurtig h. Neurology. 1994 Feb;44(2):266-8. doi: 10.1212/wnl.44.2.266. Neurology. 1994. PMID: 8309571

9

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.

Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, Mozley PD, Plossl K, Udeshi M, Hurtig H. Swanson RL, et al. Among authors: hurtig h. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):302-7. doi: 10.1007/s00259-004-1667-x. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791439 Clinical Trial.

10

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.

Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Siderowf A, et al. Among authors: hurtig h. Mov Disord. 2006 Jun;21(6):746-53. doi: 10.1002/mds.20786. Mov Disord. 2006. PMID: 16463342 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters